This is a firm fixed-price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Revvity Health Sciences, Inc., a for-profit manufacturer of medical imaging products and services. The $23,616.00 contract is for the maintenance of Zephyr workstations. No set-aside was used for this award. Revvity Health Sciences has previously provided a variety of medical devices, laboratory equipment, and maintenance services to federal...
This is a $36,372.00 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Revvity Health Sciences, Inc. for equipment service and maintenance. The contract has a period of performance through March 31, 2025 and is not set aside for any specific business size or type. Revvity Health Sciences, Inc. is a for-profit manufacturer that supplies medical imaging products and services to federal agencies, including the National Institutes of Health,...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Revvity Health Sciences, Inc. for a service maintenance agreement on laboratory equipment. The contract has a ceiling value of $76,496.40 and a period of performance through August 19, 2024. The contract was not set-aside for any specific business type. Revvity Health Sciences, Inc. is a subsidiary of the parent company Revvity Inc. Medical Imaging Division, which has a history...
This is a $4,551,697.94 firm-fixed price maintenance agreement between the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) and Revvity Health Sciences, Inc., a manufacturer of medical imaging products and provider of related services. The contract, which has a period of performance through May 31, 2022, does not have a set-aside designation. Revvity Health Sciences is a subsidiary of the parent company Revvity Inc. Through this agreement, Revvity Health...
This firm-fixed price purchase order was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Revvity Health Sciences, Inc. in the amount of $245,517.00. The contract has a completion date of January 1, 2023 and does not include a set-aside designation. The contract provides medical imaging products and services to the CDC, likely in support of the agency's public health research and disease surveillance programs. Revvity Health Sciences,...
This federal contract award to Revvity Health Sciences, Inc. (a subsidiary of Revvity Inc.) was issued by the Centers for Disease Control and Prevention (CDC) for the provision of a SCICLONE NGSX WORKSTATION, a medical imaging product. The $209,609.14 firm fixed-price contract has a performance period ending on May 8, 2015. The contract was not set aside for any specific business type. Revvity Health Sciences has a history of providing a wide range of medical devices and laboratory equipment...
The Centers for Disease Control and Prevention (CDC) awarded Revvity Health Sciences, Inc. a firm fixed-price purchase order contract for preventive maintenance services on liquid scintillation equipment. The contract, valued at $79,092.00, has a period of performance through August 31, 2026. Revvity Health Sciences, Inc. is a for-profit medical imaging products and services provider that has received multiple prime contracts and subcontracts with federal agencies like the NIH, DoD, and VA for...
The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a firm fixed-price purchase order to Revvity Health Sciences, Inc. for the delivery of a SCICLONE G3 NGSX HT WORKSTATION laboratory instrument. The contract has a potential value of $242,491.55 and a period of performance through September 30, 2020. No set-aside designation was used for this award. Revvity Health Sciences, Inc. is a for-profit manufacturer that provides a range of medical...
This federal contract was awarded by the Department of Health and Human Services' Centers for Disease Control and Prevention (CDC) to Revvity Health Sciences, Inc., a for-profit manufacturer of medical imaging products and services. The $106,790.03 firm-fixed-price contract is for the delivery of the ZEPHYR G3 NGS system, with a period of performance ending on September 15, 2020. The contract did not utilize a set-aside designation. Revvity Health Sciences, Inc. is a subsidiary of the parent...
This federal contract award to Revvity Health Sciences, Inc. is a firm fixed-price Purchase Order valued at $20,246.40 with the Centers for Disease Control and Prevention (CDC) for laboratory equipment and services. The award has a period of performance through March 24, 2023. Revvity Health Sciences, Inc. is a subsidiary of the parent company Revvity Inc., which provides medical imaging products and services to federal agencies through prime contracts and subcontracts. This award does not...